natgillin/translations-raw huggingface dataset:
Following the Commission’s advice, one of the applicants informed the Commission of its intention to discontinue its participation in the review programme in accordance with Article 11(1) of Regulation (EC) No 1451/2007 on 10 September 2009.
Po nasvetu Komisije je eden od vlagateljev obvestil Komisijo, da namerava z 10. septembrom 2009 prekiniti svoje sodelovanje v programu pregledovanja v skladu s členom 11(1) Uredbe (ES) št. 1451/2007.
The other applicant chose to remain in the review programme despite the advice.
Drugi vlagatelj se je odločil, da kljub nasvetu ostane v programu pregledovanja.
allowing Member States to extend provisional authorisations granted for the new active substances acequinocyl, aminopyralid, ascorbic acid, flubendiamide, gamma-cyhalothrin, ipconazole, metaflumizone, orthosulfamuron, Pseudomonas sp. strain DSMZ 13134, pyridalil, pyroxsulam, spiromesifen, thiencarbazone and topramezone
o dovoljenju državam članicam za podaljšanje začasnih registracij, izdanih za nove aktivne snovi acekvinocil, aminopiralid, askorbinska kislina, flubendiamid, gama-cihalotrin, ipkonazol, metaflumizon, ortosulfamuron, Pseudomonas sp. sev DSMZ 13134, piridalil, piroksulam, spiromesifen, tienkarbazon in topramezon
(notified under document C(2013) 2246)
(notificirano pod dokumentarno številko C(2013) 2246)
Commission Decision 2005/778/EC [4] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo Komisije 2005/778/ES [4] je bilo potrjeno, da je dokumentacija popolna ter da načeloma izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k navedeni direktivi.
In accordance with Article 6(2) of Directive 91/414/EEC, in September 2004 the Netherlands received an application from Citrex Nederland BV for the inclusion of the active substance ascorbic acid in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Nizozemska septembra 2004 prejela zahtevek družbe Citrex Nederland BV za vključitev aktivne snovi askorbinska kislina v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2005/751/EC [5] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo Komisije 2005/751/ES [5] je bilo potrjeno, da je dokumentacija popolna ter da načeloma izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k navedeni direktivi.
In accordance with Article 6(2) of Directive 91/414/EEC, in August 2001 the United Kingdom received an application from Pytech Chemicals GmbH for the inclusion of the active substance gamma-cyhalothrin in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Združeno kraljestvo avgusta 2001 prejelo zahtevek družbe Pytech Chemicals GmbH za vključitev aktivne snovi gama-cihalotrin v Prilogo I k Direktivi 91/414/EGS.
In accordance with Article 6(2) of Directive 91/414/EEC, in March 2007 the United Kingdom received an application from Kureha GmbH for the inclusion of the active substance ipconazole in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Združeno kraljestvo marca 2007 prejelo zahtevek družbe Kureha GmbH za vključitev aktivne snovi ipkonazol v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2008/20/EC [8] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo Komisije 2008/20/ES [8] je bilo potrjeno, da je dokumentacija popolna ter da načeloma vsebuje zahtevane podatke in informacije iz prilog II in III k navedeni direktivi.
In accordance with Article 6(2) of Directive 91/414/EEC, in November 2005 the United Kingdom received an application from BASF SE for the inclusion of the active substance metaflumizone in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Združeno kraljestvo novembra 2005 prejelo zahtevek družbe BASF SE za vključitev aktivne snovi metaflumizon v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2006/517/EC [9] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo Komisije 2006/517/ES [9] je bilo potrjeno, da je dokumentacija popolna ter da načeloma vsebuje zahtevane podatke in informacije iz prilog II in III k navedeni direktivi.
In accordance with Article 6(2) of Directive 91/414/EEC, in July 2005 Italy received an application from Isagro SpA for the inclusion of the active substance orthosulfamuron in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Italija julija 2005 prejela zahtevek družbe Isagro SpA za vključitev aktivne snovi ortosulfamuron v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2006/806/EC [10] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo Komisije 2006/806/ES [10] je bilo potrjeno, da je dokumentacija popolna ter da načeloma vsebuje zahtevane podatke in informacije iz prilog II in III k navedeni direktivi.
In accordance with Article 6(2) of Directive 91/414/EEC, in August 2008 the Netherlands received an application from Sourcon-Padena GmbH & Co KG for the inclusion of the active substance Pseudomonas sp. strain DSMZ 13134 in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Nizozemska avgusta 2008 prejela zahtevek družbe Sourcon-Padena GmbH & Co KG za vključitev aktivne snovi Pseudomonas sp. sev DSMZ 13134 v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2008/599/EC [11] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo Komisije 2008/599/ES [11] je bilo potrjeno, da je dokumentacija popolna ter da načeloma vsebuje zahtevane podatke in informacije iz prilog II in III k navedeni direktivi.
In accordance with Article 6(2) of Directive 91/414/EEC, in March 2006 the Netherlands received an application from Sumitomo Chemical Agro Europe SAS for the inclusion of the active substance pyridalil in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Nizozemska marca 2006 prejela zahtevek družbe Sumitomo Chemical Agro Europe SAS za vključitev aktivne snovi piridalil v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2007/669/EC [12] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo Komisije 2007/669/ES [12] je bilo potrjeno, da je dokumentacija popolna ter da načeloma vsebuje zahtevane podatke in informacije iz prilog II in III k navedeni direktivi.
Commission Decision 2007/277/EC [13] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo Komisije 2007/277/ES [13] je bilo potrjeno, da je dokumentacija popolna ter da načeloma izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k navedeni direktivi.
In accordance with Article 6(2) of Directive 91/414/EEC, in April 2002 the United Kingdom received an application from Bayer CropScience AG for the inclusion of the active substance spiromesifen in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Združeno kraljestvo aprila 2002 prejelo zahtevek družbe Bayer CropScience AG za vključitev aktivne snovi spiromesifen v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2003/105/EC [14] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo Komisije 2003/105/ES [14] je bilo potrjeno, da je dokumentacija popolna ter da načeloma izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k navedeni direktivi.
Commission Decision 2008/566/EC [15] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo Komisije 2008/566/ES [15] je bilo potrjeno, da je dokumentacija popolna ter da načeloma izpolnjuje zahteve po podatkih in informacijah iz prilog II in III k navedeni direktivi.
In accordance with Article 6(2) of Directive 91/414/EEC, in May 2003 France received an application from BASF SE for the inclusion of the active substance topramezone in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Francija maja 2003 prejela zahtevek družbe BASF SE za vključitev aktivne snovi topramezon v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2003/850/EC [16] confirmed that the dossier was complete and could be considered as satisfying, in principle, the data and information requirements of Annex II and Annex III to that Directive.
Z Odločbo Komisije 2003/850/ES [16] je bilo potrjeno, da je dokumentacija popolna ter da načeloma vsebuje zahtevane podatke in informacije iz prilog II in III k navedeni direktivi.
The rapporteur Member States submitted the draft assessment reports to the Commission on 15 March 2005 (acequinocyl), on 10 September 2007 (ascorbic acid), on 22 August 2006 (aminopyralid), on 1 September 2008 (flubendiamide), on 13 September 2012 (gamma-cyhalothrin), on 29 May 2008 (ipconazole), on 15 April 2008 (metaflumizone), on 19 July 2012 (orthosulfamuron), on 3 November 2009 (Pseudomonas sp. strain DSMZ 13134), on 13 January 2009 (pyridalil), on 20 March 2008 (pyroxsulam), on 9 March 2004 (spiromesifen), on 17 December 2008 (thiencarbazone) and on 26 July 2007 (topramezone).
Države članice poročevalke so Komisiji predložile osnutke poročil o oceni 15. marca 2005 (acekvinocil), 10. septembra 2007 (askorbinska kislina), 22. avgusta 2006 (aminopiralid), 1. septembra 2008 (flubendiamid), 13. septembra 2012 (gama-cihalotrin), 29. maja 2008 (ipkonazol), 15. aprila 2008 (metaflumizon), 19. julija 2012 (ortosulfamuron), 3. novembra 2009 (Pseudomonas sp. sev DSMZ 13134), 13. januarja 2009 (piridalil), 20. marca 2008 (piroksulam), 9. marca 2004 (spiromesifen), 17. decembra 2008 (tienkarbazon) in 26. julija 2007 (topramezon).
Following submission of the draft assessment reports by the rapporteur Member States, it has been found to be necessary to request further information from the applicants and to have the rapporteur Member States examine that information and submit their assessment.
Po predložitvi osnutkov poročil o oceni držav članic poročevalk je bilo ugotovljeno, da je treba od vlagateljev zahtevati dodatne informacije, ki jih morajo države članice poročevalke pregledati in nato predložiti svojo oceno.
Therefore, the examination of the dossiers is still ongoing and it will not be possible to complete the evaluation within the timeframe provided for in Directive 91/414/EEC, read in conjunction with Commission Implementing Decisions 2011/490/EU [17] (acequinocyl, aminopyralid, flubendiamide, metaflumizone, pyroxsulam and thiencarbazone), 2011/252/EU [18] (ascorbic acid, ipconazole, Pseudomonas sp. strain DSMZ 13134, spiromesifen and topramezone) and 2011/671/EU [19] (gamma-cyhalothrin).
Zato pregled dokumentacij še vedno poteka, ocen pa ne bo mogoče končati v roku iz Direktive 91/414/EGS, ki se razlaga skupaj z izvedbenimi sklepi Komisije 2011/490/EU [17] (acekvinocil, aminopiralid, flubendiamid, metaflumizon, piroksulam in tienkarbazon), 2011/252/ES [18] (askorbinska kislina, ipkonazol, Pseudomonas sp. sev DSMZ 13134, spiromesifen in topramezon) in 2011/671/EU [19] (gama-cihalotrin).
As the evaluation so far has not identified any reason for immediate concern, Member States should be given the possibility of prolonging provisional authorisations granted for plant protection products containing the active substances concerned for a period of 24 months in accordance with the provisions of Article 8 of Directive 91/414/EEC so as to enable the examination of the dossiers to continue.
Ker do zdaj pri ocenjevanju ni bil ugotovljen nikakršen razlog za neposredno zaskrbljenost, bi bilo treba državam članicam v skladu z določbami člena 8 Direktive 91/414/EGS omogočiti 24-mesečno podaljšanje začasnih registracij za fitofarmacevtska sredstva, ki vsebujejo zadevne aktivne snovi, da se omogoči nadaljevanje pregledovanja dokumentacije.
It is expected that the evaluation and decision-making process with respect to a decision on a possible approval in accordance with Article 13(2) of Regulation (EC) No 1107/2009 for acequinocyl, aminopyralid, ascorbic acid, flubendiamide, gamma-cyhalothrin, ipconazole, metaflumizone, orthosulfamuron, Pseudomonas sp. DSMZ 13134, pyridalil, pyroxsulam, spiromesifen, thiencarbazone and topramezone will have been completed within 24 months.
Pričakuje se, da bosta ocena in postopek odločanja glede odločitve o morebitni odobritvi v skladu s členom 13(2) Uredbe (ES) št. 1107/2009 za acekvinocil, aminopiralid, askorbinsko kislino, flubendiamid, gama-cihalotrin, ipkonazol, metaflumizon, ortosulfamuron, Pseudomonas sp. sev DSMZ 13134, piridalil, piroksulam, spiromesifen, tienkarbazon in topramezon končana v 24 mesecih.
DSMZ 13134, pyridalil, pyroxsulam, spiromesifen, thiencarbazone or topramezone for a period ending on 30 April 2015 at the latest.
Države članice lahko podaljšajo začasne registracije fitofarmacevtskih sredstev, ki vsebujejo aktivne snovi acekvinocil, aminopiralid, askorbinsko kislino, flubendiamid, gama-cihalotrin, ipkonazol, metaflumizon, ortosulfamuron, Pseudomonas sp. sev DSMZ 13134, piridalil, piroksulam, spiromesifen, tienkarbazon ali topramezon, najpozneje do 30. aprila 2015.
This Decision shall expire on 30 April 2015.
Ta sklep preneha veljati 30. aprila 2015.
OJ L 329, 25.11.2006, p. 74.
UL L 329, 25.11.2006, str. 74.
OJ L 201, 4.8.2011, p. 16.
UL L 201, 4.8.2011, str. 16.
OJ L 106, 27.4.2011, p. 11.
UL L 106, 27.4.2011, str. 11.
OJ L 267, 12.10.2011, p. 19.
UL L 267, 12.10.2011, str. 19.
Article 1 Member States may extend provisional authorisations for plant protection products containing acequinocyl, aminopyralid, ascorbic acid, flubendiamide, gamma-cyhalothrin, ipconazole, metaflumizone, orthosulfamuron, Pseudomonas sp.
Člen 1
on the position to be adopted, on behalf of the European Union, in the EEA Joint Committee concerning an amendment to Annex XXI (Statistics) to the EEA Agreement
o stališču, ki ga je treba v imenu Evropske unije sprejeti v Skupnem odboru EGP glede spremembe Priloge XXI (Statistika) k Sporazumu EGP
Pursuant to Article 98 of the EEA Agreement, the EEA Joint Committee may decide to amend, inter alia, Annex XXI thereto.
V skladu s členom 98 Sporazuma EGP se lahko Skupni odbor EGP med drugim odloči spremeniti Prilogo XXI k Sporazumu.
Annex XXI to the EEA Agreement contains specific provisions and arrangements concerning Statistics.
Priloga XXI k Sporazumu EGP vsebuje posebne določbe in pravila v zvezi s statistiko.
Commission Regulation (EU) No 555/2012 of 22 June 2012 amending Regulation (EC) No 184/2005 of the European Parliament and of the Council on Community statistics concerning balance of payments, international trade in services and foreign direct investment, as regards the update of data requirements and definitions [3] should be incorporated in the EEA Agreement, with certain adaptations for Norway, Iceland and Liechtenstein.
Uredbo Komisije (EU) št. 555/2012 z dne 22. junija 2012 o spremembi Uredbe (ES) št. 184/2005 Evropskega parlamenta in Sveta o statistiki Skupnosti glede plačilne bilance, mednarodne trgovine s storitvami in neposrednih tujih naložb v zvezi s posodobitvijo zahtev za podatke in opredelitev [3] bi bilo treba vključiti v Sporazum EGP, z nekaterimi prilagoditvami za Norveško, Islandijo in Lihtenštajn.
Annex XXI to the EEA Agreement should therefore be amended accordingly.
Prilogo XXI k Sporazumu EGP bi bilo zato treba ustrezno spremeniti.
The position to be adopted, on behalf of the European Union, in the EEA Joint Committee on the proposed amendment to Annex XXI (Statistics) to the EEA Agreement shall be based on the draft Decision of the EEA Joint Committee attached to this Decision.
Stališče, ki se v imenu Evropske unije sprejme v Skupnem odboru EGP glede predlagane spremembe Priloge XXI (Statistika) k Sporazumu EGP, temelji na osnutku sklepa Skupnega odbora EGP, priloženega temu sklepu.
32012 R 0555: Commission Regulation (EU) No 555/2012 of 22 June 2012 (OJ L 166, 27.6.2012, p. 22).’
32012 R 0555: Uredba Komisije (EU) št. 555/2012 z dne 22. junija 2012 (UL L 166, 27.6.2012, str. 22).“;
The text of the adaptation is replaced by the following:
besedilo prilagoditve se nadomesti z naslednjim:
The texts of Regulation (EU) No 555/2012 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Besedilo Uredbe (EU) št. 555/2012 v islandskem in norveškem jeziku, ki se objavi v Dopolnilu EGP k Uradnemu listu Evropske unije, je verodostojno.
This Decision shall enter into force on …, provided that all the notifications under Article 103(1) of the EEA Agreement have been made [2].
Ta sklep začne veljati […] pod pogojem, da so bila predložena vsa uradna obvestila v skladu s členom 103(1) Sporazuma EGP [2].
on the position to be adopted, on behalf of the European Union, in the EEA Joint Committee concerning an amendment to Protocol 31 to the EEA Agreement, on cooperation in specific fields outside the four freedoms
o stališču, ki ga je treba v imenu Evropske unije sprejeti v Skupnem odboru EGP glede spremembe Protokola 31 k Sporazumu EGP o sodelovanju na posebnih področjih, za katera ne veljajo štiri temeljne svobode
Pursuant to Article 98 of the EEA Agreement, the EEA Joint Committee may decide to amend, inter alia, Protocol 31 thereto.
V skladu s členom 98 Sporazuma EGP se lahko Skupni odbor EGP med drugim odloči spremeniti Protokol 31 k Sporazumu EGP.
Protocol 31 to the EEA Agreement contains specific provisions and arrangements concerning cooperation in specific fields outside the four freedoms.
Protokol 31 k Sporazumu EGP vsebuje posebne določbe in pravila glede sodelovanja na posebnih področjih, za katera ne veljajo štiri temeljne svobode.
It is appropriate to extend the cooperation of the Contracting Parties to the EEA Agreement to the actions funded from the 04 01 04 08 and 04 03 05 budget lines for the financial year 2013.
Sodelovanje pogodbenic Sporazuma EGP je primerno razširiti na dejavnosti, ki se financirajo iz proračunskih vrstic 04 01 04 08 in 04 03 05 za proračunsko leto 2013.
The position to be adopted, on behalf of the European Union, in the EEA Joint Committee on the proposed amendment to Protocol 31 to the EEA Agreement, on cooperation in specific fields outside the four freedoms, shall be based on the draft Decision of the EEA Joint Committee attached to this Decision.
Stališče, ki ga je treba v imenu Evropske unije sprejeti v Skupnem odboru EGP glede predlagane spremembe Protokola 31 k Sporazumu EGP o sodelovanju na posebnih področjih, za katera ne veljajo štiri temeljne svobode, temelji na osnutku sklepa Skupnega odbora EGP, priloženega temu sklepu.
DECISION OF THE EEA JOINT COMMITTEE No …/2013
SKLEP SKUPNEGA ODBORA EGP št …/2013
Protocol 31 to the EEA Agreement should therefore be amended in order to allow for that extended cooperation to take place from 1 January 2013,
Protokol 31 k Sporazumu EGP bi bilo zato treba ustrezno spremeniti tako, da se omogoči razširjeno sodelovanje s 1. januarjem 2013 –
The words ‘year 2012’ are replaced by ‘years 2012 and 2013’.
Besedilo „proračunsko leto 2012“ se nadomesti s „proračunski leti 2012 in 2013“.
Article 145 of the Treaty on the Functioning of the European Union (TFEU) provides that the Member States and the Union are to work towards developing a coordinated strategy for employment and particularly for promoting a skilled, trained and adaptable workforce and labour markets responsive to economic change with a view to achieving the objectives defined in Article 3 of the Treaty on European Union.
V členu 145 Pogodbe o delovanju Evropske unije (PDEU) je določeno, da si države članice in Unija prizadevajo za razvoj usklajene strategije zaposlovanja in zlasti za spodbujanje kvalificirane, usposobljene in prilagodljive delovne sile in trgov dela, ki se prilagajajo gospodarskim spremembam, z namenom, da bi dosegle cilje, opredeljene v členu 3 Pogodbe o Evropski uniji (PEU).
The Europe 2020 strategy proposed by the Commission enables the Union to turn its economy towards smart, sustainable and inclusive growth, accompanied by high level employment, productivity and social cohesion.
„Strategija Evropa 2020“, ki jo je predlagala Komisija, omogoča Uniji, da svoje gospodarstvo usmerja k pametni, trajnostni in vključujoči rasti, ki jo bo spremljala visoka stopnja zaposlenosti, produktivnosti in socialne kohezije.
Furthermore, on 21 October 2010, the Council adopted its Decision 2010/707/EU on guidelines for the employment policies of the Member States [4] (‘employment guidelines’).
Po tem je Svet dne 21. oktobra 2010 sprejel Sklep 2010/707/EU o smernicah za politike zaposlovanja držav članic [4] (v nadaljnjem besedilu: smernice za zaposlovanje).
Those sets of guidelines form the integrated guidelines for implementing the Europe 2020 strategy.
Navedene smernice skupaj prestavljajo integrirane smernice za izvajanje Strategije Evropa 2020.
Five headline targets, listed under the relevant integrated guidelines, constitute shared objectives which guide the action of the Member States, taking into account their relative starting positions and national circumstances as well as the positions and circumstances of the Union.
Pet krovnih ciljev, navedenih pod ustreznimi smernicami, predstavlja skupne cilje, na katerih temelji ukrepanje držav članic ob upoštevanju njihovih različnih izhodiščnih položajev in nacionalnih okoliščin ter stališč in okoliščin Unije.
The European Employment Strategy plays the leading role in the implementation of the employment and labour market objectives of the Europe 2020 strategy.
Evropska strategija zaposlovanja igra vodilno vlogo pri uresničevanju ciljev Strategije Evropa 2020, ki zadevajo zaposlovanje in trge dela.
The employment guidelines should form the basis for any country-specific recommendations that the Council may address to the Member States under Article 148(4) of the TFEU, in parallel with the country-specific recommendations addressed to the Member States under Article 121(2) of the TFEU.
Smernice za zaposlovanje bi morale biti podlaga za vsa priporočila posameznim državam, ki jih lahko Svet naslovi na države članice v skladu s členom 148(4) PDEU, skupaj s priporočili posameznim državam, ki so naslovljena na države članice v skladu s členom 121(2) PDEU.